BeStock  
Markets › Compare › RAPP vs NRIX

RAPP vs NRIX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
RAPP · Rapport Therapeutics$23.16 ▼ 1.82%
NRIX · Nurix Therapeutics$12.85 ▼ 5.51%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6899130161192Nov 24, '25May 26, '26Nov 20, '26
  • RAPP -18.2%
  • NRIX -25.1%

Head to head

MetricRAPPNRIX
Price$23.16$12.85
Change today▼ 1.82%▼ 5.51%
Market cap$1.37B$1.40B
Return, 3 months-53.1%-51.1%
Return, year to date-23.7%-32.3%
Return, 1 year-15.0%-23.3%
P/E (TTM)–5.3
P/B3.51.4
P/E percentile vs own 5y73rd98th
Dividend yield––
Revenue growth (YoY, latest qtr)–+8,426.3%
Net profit growth (YoY)-49.4%+736.2%
Gross margin––
Operating margin-838.1%41.3%
Net margin-752.4%42.0%
Return on equity-33.3%44.0%
Analyst target vs. price+193.6%+174.9%
Analyst buy share100%100%
RSI (14)3721
30-day volatility99.9%149.6%
Max drawdown, 1 year-57.1%-53.8%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NRIX is the largest of the group by market value.
  • RAPP has returned the most over the past year.
  • NRIX keeps the most profit per dollar of sales.
  • RAPP has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top